SavedAdd your journal

Journals / Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi / 2017 / Cilt: 31 - Sayı: 3

Thanatophoric Dysplasia Detected During Prenatal Period

Prenatal dönemde saptanan Tanatoforik Displazi olgusu

Hande ÖZKALAYCI
Esra ATAMAN
MURAT CELİLOĞLU
ERDENER ÖZER
AYFER ÜLGENALP
MURAT DERYA ERÇAL
Elçin BORA
Pages
181–186
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we presented a case with abnormal USG findings during perinatal period and detected to carry a p.R248C mutation in FGFR3 gene in amniosynthesis fluid.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thanatophoric dysplasia is one of the newborn’s dwarfism syndromes usually resulting in death during perinatal period and manifesting as short extremities.
📊
Key Findings & Data:This is caused by mutations in the fibroblast growth factor receptor 3 (FGFR3) gene and shows autosomal dominant inheritance model.
💡
Conclusion & Impact:In this report, we presented a case with abnormal USG findings during perinatal period and detected to carry a p.R248C mutation in FGFR3 gene in amniosynthesis fluid.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Tanatoforik Displazi · Fibroblast Büyüme Faktörü · FGFR3 Geni

Abstract

Thanatophoric dysplasia is one of the newborn’s dwarfism syndromes usually resulting in death during perinatal period and manifesting as short extremities. It is characterized by macrocephaly, prominent forehead, narrow thorax, short extremities, flattened vertebral bodies, curved femurs. This is caused by mutations in the fibroblast growth factor receptor 3 (FGFR3) gene and shows autosomal dominant inheritance model. In this report, we presented a case with abnormal USG findings during perinatal period and detected to carry a p.R248C mutation in FGFR3 gene in amniosynthesis fluid.

Özet

Tanatoforik displazi, genelde perinatal dönemde ölümle sonuçlanan ve kısa ekstremiteler ile kendini gösteren yenidoğanın cücelik sendromlarından biridir. Makrosefali, belirgin alın, dar toraks, vertebralarda düzleşme, ekstremitelerde kısalık, femurda eğrilme ile karakterizedir. Fibroblast büyüme faktörü reseptörü 3 (FGFR3) genindeki mutasyonlardan kaynaklanır ve otozomal dominant kalıtım modeli gösterir. Bu makalede, prenatal dönemde anormal USG bulguları olan, amniyosentez materyalinden yapılan FGFR3 gen analizi ile p.R248C mutasyonu saptanan bir olgu anlatılmıştır.

🔖

Cite This Article

ÖZKALAYCI, H., ATAMAN, E., CELİLOĞLU, M., ÖZER, E., ÜLGENALP, A., ERÇAL, M. D., BORA, E. (2017). Thanatophoric Dysplasia Detected During Prenatal Period. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, Cilt: 31 - Sayı: 3, 181–186. https://ajindex.com/articles/222465

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Referans1 Maroteaux P, Lamy M, Robert J-M. Le nanisme thanatophore. Presse Med 1967
  2. 2519–24. Referans2 Dighe M, Fligner C, Cheng E, Warren B, Dubinsky T. Fetal skeletal dysplasia: an approach to diagnosis with illustrative cases. Radiographics 2008
  3. Referans3 Orioli IM, Castilla EE, Barbosa-Neto JG. The birth prevalence rates for the skeletal dysplasias. J Med Genet 1986
  4. 328–32. Referans4 Martínez-Frías ML, Ramos-Arroyo MA, Salvador J. Thanatophoric dysplasia: an autosomal dominant condition?. Am J Med Genet 1988
  5. Referans5 Wilcox WR, Tavormina PL, Krakow D, et al. Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Am J Med Genet 1998
  6. Referans6 Hatzaki A, Sifakis S, Apostolopoulou D, et al. FGFR3 related skeletal dysplasias diagnosed prenatally by ultrasonography and molecular analysis: Presentation of 17 cases. Am J Med Genet Part A 2011
  7. 2426–35. Referans7 Baker KM, Olson DS, Harding CO, Pauli RM. Long term survival in typical thanatophoric dysplasia type 1. Am J Med Genet 1997
  8. Referans8 Langer LO, Yang SS, Hall JG, et al. Thanatophoric dysplasia and cloverleaf skull. Am J Med Genet 1987
  9. 167–79. Referans9 Bonafe L, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders. Am J Med Genet Part A 2015
  10. 9999A:1–24. Referans10 Martínez-Frías ML, de Frutos CA, Bermejo E, ECEMC Working Group, Nieto MA. Review of the recently defined molecular mechanisms underlying thanatophoric dysplasia and their potential therapeutic implications for achondroplasia. Am J Med Genet A 2010
  11. 152A: 245-55. Referans11. Foldynova-Trantirkova S, Wilcox WR, Krejci P. Sixteen years and counting: The current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias. Hum Mutat 2012
  12. 29–41. Referans12. Johnson DE, Williams LT. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993
  13. Referans13 Webster MK, D'Avis PY, Robertson SC, Donoghue DJ. Profound Ligand-Independent Kinase Activation of Fibroblast Growth Factor Receptor 3 by the Activation Loop Mutation Responsible for a Lethal Skeletal Dysplasia, Thanatophoric Dysplasia Type II. Mol Cell Biol 1996
  14. Referans14 Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke Craniosynostosis, and Crouzon Syndrome with Acan